Position in CDNA
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$352,060
-$364,803 QoQ
Shares Held
12,353
-70.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#146
of 225 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $30,838,073 across 12 Diagnostics & Research names. CDNA ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
16,330 | $8,596,765 | |
| 2 | GH |
Guardant Health, Inc.
|
52,547 | $7,883,626 | |
| 3 | ILMN |
Illumina, Inc.
|
18,655 | $3,280,108 | |
| 4 | ADPT |
Adaptive Biotechnologies Corp
|
33,784 | $2,898,688 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
10,950 | $2,115,759 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
27,521 | $1,889,316 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
2,669 | $1,338,129 | |
| 8 | LH |
Labcorp Holdings Inc.
|
4,074 | $1,140,720 |
All Filings in CDNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,060 | 12,353 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $716,863 | 41,294 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $490,744 | 26,048 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $380,521 | 19,474 | Shares | Sole | 2025-08-01 | |
| 2024-06-30 | $721,415 | 46,453 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $409,524 | 34,127 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $117,117 | 16,731 | Shares | Sole | 2023-11-14 | |
| 2021-09-30 | $331,615 | 5,233 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $594,698 | 8,734 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||